Austerity cost to French industry could be well over €1bn
This article was originally published in Scrip
If the French pharmaceutical industry was worried about the impact of the 2012 social security financing bill (PLFSS), its concerns will only have heightened after the deepening economic crisis in Europe led the government to announce yet more austerity measures that could see the industry more than a billion euros worse off.
You may also be interested in...
France has announced a number of emergency measures to protect drug supplies threatened by the spread of the coronavirus.
A number of countries are resorting to extreme measures such as export bans to preserve stocks of medicines for the COVID-19 pandemic. Belgium is among the latest to impose an export prohibition, but might it fall foul of the EU’s export regulations?
In addition to our daily in-depth coverage of key events relating to the COVID-19 pandemic, we’re bringing you a periodic round-up of other developments. This edition covers Europe and other countries.